Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q6CMN5

Entry ID Method Resolution Chain Position Source
AF-Q6CMN5-F1 Predicted AlphaFoldDB

No variants for Q6CMN5

Variant ID(s) Position Change Description Diseaes Association Provenance
No variants for Q6CMN5

No associated diseases with Q6CMN5

3 regional properties for Q6CMN5

Type Name Position InterPro Accession
domain Exonuclease, RNase T/DNA polymerase III 937 - 1119 IPR013520
domain PAN2, UCH domain 513 - 861 IPR028881
domain Ubiquitin specific protease domain 513 - 887 IPR028889

Functions

Description
EC Number 3.1.13.4 Exoribonucleases producing 5'-phosphomonoesters
Subcellular Localization
  • Cytoplasm
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

1 GO annotations of cellular component

Name Definition
PAN complex A complex that possesses poly(A)-specific ribonuclease activity; catalyzes the message-specific shortening of mRNA poly(A) tails. Contains at least two subunits, known as Pan2p and Pan3p in Saccharomyces.

3 GO annotations of molecular function

Name Definition
metal ion binding Binding to a metal ion.
nucleic acid binding Binding to a nucleic acid.
poly(A)-specific ribonuclease activity Catalysis of the exonucleolytic cleavage of poly(A) to 5'-AMP.

3 GO annotations of biological process

Name Definition
mRNA processing Any process involved in the conversion of a primary mRNA transcript into one or more mature mRNA(s) prior to translation into polypeptide.
nuclear-transcribed mRNA poly(A) tail shortening Shortening of the poly(A) tail of a nuclear-transcribed mRNA from full length to an oligo(A) length.
postreplication repair The conversion of DNA-damage induced single-stranded gaps into large molecular weight DNA after replication. Includes pathways that remove replication-blocking lesions in conjunction with DNA replication.

No homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
No homologous proteins
10 20 30 40 50 60
MNNWQLSYQS PEDLTYHLKK PYLQYDKKEK QVTKVVFDTE ANLIWAGDSY GRVSSYDPTY
70 80 90 100 110 120
SLYTRHTAHI GSMPVVDLLS NKNGILSLSS DSLHFSNRRG VTQMSLTSAD IAQLSDMKTM
130 140 150 160 170 180
CYYTNNQNQV LCAGGNTASG IISVDLIKGT LASSTYFTSK VKHMSSNNKL VAIGKQAGSI
190 200 210 220 230 240
DLFDPVSNRV IHSLSGHSAS ITSMDFKDNT LVTAGKSKTF GYLQSDQFIN VYDVRIMKQL
250 260 270 280 290 300
PPISFSKTPN FVGNHTSSKF PIGADFLQLH PVLPTVVAVA SSSGSFDFID LVNPSLRTPY
310 320 330 340 350 360
IHPCKSISQF TLSPSGDYLA FLEEESMINM WNRSNSMSGF TNSAAVLEYQ DYPEDSFIPY
370 380 390 400 410 420
RVEVGQESYP LSSIGLPYYS ETLLSAWPHT VFKTEGIISK KIEGSSSSET DNNSTKSVNR
430 440 450 460 470 480
SLSHLSSSKY SLQPYNKFKY GPRNVIEPYK SLRERRKKMV STTEDNQHRK ELLEYKPSNN
490 500 510 520 530 540
IDIPPAYSKL QMIYGKFGVM DFDFGGFNTT QYSGLETDID CVYINEIIHL YRFVPEVYNF
550 560 570 580 590 600
VVNCLEDEHI QEKSVLTELG FLFDMMTRAN GKICRASNFV DVLESISTAN ELGLFTDEIS
610 620 630 640 650 660
TVSGHAGKPS LDEGNLSSHI YNLNLSVDAD AEEIMKRSYG KYMTVAQKFN IFLLDRLISE
670 680 690 700 710 720
EVERKLHSTD AIVLEELFGL NVDTEIHTLS TCGNFVRQPH LVSSLVVLSP ASNNVKYSNK
730 740 750 760 770 780
KLSNQTILPY IESSMCRFKQ LTARCSKCEK LQNQEYESIV RNLPPLLSLN ICLSPEEWTT
790 800 810 820 830 840
AKTVNGWLSN HFFATISKDR PILKLQATDL KTSNAIFKYE LMSYVARITD DFGEEHLVTY
850 860 870 880 890 900
AKILDQKIQQ YKWYMFNDFL VQEIDEDEAL NISYWWKTPE IVVYSDAEEI RKPFVSVSKL
910 920 930 940 950 960
KVDTDILYRD YFSEGIRKDV IRQYRLLTKD EAPGPGTLVA LDAEFVSLTE PYLEINCKGM
970 980 990 1000 1010 1020
KTLLKPAKKS LARVSLLRGE GELEGVPFID DYIINECHIE DYLTQFSGIE PGDLDPKLSK
1030 1040 1050 1060 1070 1080
KSLVKRQVFY RKMWLLLQLG CVFVGHGLTN DFRQINIYVP ESQIRDTSLY YLKGKRYLSL
1090 1100 1110 1120 1130 1140
RYLAFAVLRK QVQTGNHDSI EDAHTALLLY RKYLELKEKG VFEMYLENIY DEGRKFGFKV
PDTI